Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2009

01.11.2009 | Epidemiology

A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women

verfasst von: Zhanwei Wang, Yan Xu, Jinhai Tang, Hongxia Ma, Jianwei Qin, Chen Lu, Xuechen Wang, Zhibin Hu, Xinru Wang, Hongbing Shen

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

RecQ helicases play a central role in maintaining genome stability and may interact with some important cancer-related proteins such as BRCA1. Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature aging and cancer predisposition, including breast cancer. In this case–control study of 1,004 breast cancer cases and 1,008 controls, we tested the hypothesis that non-conservative amino acid exchanges in WRN (leu1074Phe), BLM (Met298Thr) and BRCA1 (Pro871Leu) are independently or jointly associated with the risk of breast cancer in Chinese women. We found that the variant genotype of WRN Leu1074Phe was associated with a 1.36-fold significantly increased risk of breast cancer (OR = 1.36, 95% CI = 1.06–1.74). Moreover, a significant gene–environment interaction was evident between WRN leu1074Phe and age at menarche (P int = 0.02). Subjects carrying Phe/Phe genotype and with earlier age at menarche had 3.58-fold increased risk of breast cancer (OR = 3.58, 95% CI = 2.54–5.05). However, we did not find the significant main effect of polymorphisms in BLM and BRCA1 and also no locus–locus interactions were identified between WRN, BLM and BRCA1. These findings indicate that WRN leu1074Phe variant may contribute to the susceptibility of breast cancer in Chinese women.
Literatur
1.
Zurück zum Zitat Sharma S, Brosh RM Jr (2007) Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS One 2:e1297. doi:10.1371/journal.pone.0001297 Sharma S, Brosh RM Jr (2007) Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges. PLoS One 2:e1297. doi:10.​1371/​journal.​pone.​0001297
6.
Zurück zum Zitat Cheng WH, Kusumoto R, Opresko PL, Sui X, Huang S, Nicolette ML, Paull TT, Campisi J, Seidman M, Bohr VA (2006) Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res 34:2751–2760. doi:10.1093/nar/gkl362 CrossRefPubMed Cheng WH, Kusumoto R, Opresko PL, Sui X, Huang S, Nicolette ML, Paull TT, Campisi J, Seidman M, Bohr VA (2006) Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res 34:2751–2760. doi:10.​1093/​nar/​gkl362 CrossRefPubMed
8.
Zurück zum Zitat Kamath-Loeb AS, Welcsh P, Waite M, Adman ET, Loeb LA (2004) The enzymatic activities of the Werner syndrome protein are disabled by the amino acid polymorphism R834C. J Biol Chem 279:55499–55505. doi:10.1074/jbc.M407128200 CrossRefPubMed Kamath-Loeb AS, Welcsh P, Waite M, Adman ET, Loeb LA (2004) The enzymatic activities of the Werner syndrome protein are disabled by the amino acid polymorphism R834C. J Biol Chem 279:55499–55505. doi:10.​1074/​jbc.​M407128200 CrossRefPubMed
9.
Zurück zum Zitat Ogata N, Shiraki M, Hosoi T, Koshizuka Y, Nakamura K, Kawaguchi H (2001) A polymorphic variant at the Werner helicase (WRN) gene is associated with bone density, but not spondylosis, in postmenopausal women. J Bone Miner Metab 19:296–301. doi:10.1007/s007740170013 CrossRefPubMed Ogata N, Shiraki M, Hosoi T, Koshizuka Y, Nakamura K, Kawaguchi H (2001) A polymorphic variant at the Werner helicase (WRN) gene is associated with bone density, but not spondylosis, in postmenopausal women. J Bone Miner Metab 19:296–301. doi:10.​1007/​s007740170013 CrossRefPubMed
11.
Zurück zum Zitat Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B (2006) Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis 27:1655–1660. doi:10.1093/carcin/bgi374 CrossRefPubMed Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B (2006) Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis 27:1655–1660. doi:10.​1093/​carcin/​bgi374 CrossRefPubMed
12.
Zurück zum Zitat Kohno T, Sakiyama T, Kunitoh H, Goto K, Nishiwaki Y, Saito D, Hirose H, Eguchi T, Yanagitani N, Saito R, Sasaki-Matsumura R, Mimaki S, Toyama K, Yamamoto S, Kuchiba A, Sobue T, Ohta T, Ohki M, Yokota J (2006) Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis 27:2448–2454. doi:10.1093/carcin/bgl095 CrossRefPubMed Kohno T, Sakiyama T, Kunitoh H, Goto K, Nishiwaki Y, Saito D, Hirose H, Eguchi T, Yanagitani N, Saito R, Sasaki-Matsumura R, Mimaki S, Toyama K, Yamamoto S, Kuchiba A, Sobue T, Ohta T, Ohki M, Yokota J (2006) Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis 27:2448–2454. doi:10.​1093/​carcin/​bgl095 CrossRefPubMed
16.
Zurück zum Zitat Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA (2008) Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 100:1361–1367. doi:10.1093/jnci/djn313 CrossRefPubMed Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA (2008) Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst 100:1361–1367. doi:10.​1093/​jnci/​djn313 CrossRefPubMed
18.
Zurück zum Zitat Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, Soo WK, Mahoney A, Yarovaya N, Henderson MA, Gish K, Hutchins AM, Price GR, Venter DJ (2004) Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 23:5697–5702. doi:10.1038/sj.onc.1207740 CrossRefPubMed Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, Soo WK, Mahoney A, Yarovaya N, Henderson MA, Gish K, Hutchins AM, Price GR, Venter DJ (2004) Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 23:5697–5702. doi:10.​1038/​sj.​onc.​1207740 CrossRefPubMed
20.
Zurück zum Zitat von Kobbe C, Bohr VA (2002) A nucleolar targeting sequence in the Werner syndrome protein resides within residues 949–1092. J Cell Sci 115:3901–3907. doi:10.1242/jcs.00076 CrossRef von Kobbe C, Bohr VA (2002) A nucleolar targeting sequence in the Werner syndrome protein resides within residues 949–1092. J Cell Sci 115:3901–3907. doi:10.​1242/​jcs.​00076 CrossRef
24.
Zurück zum Zitat Durocher F, Shattuck-Eidens D, McClure M, Labrie F, Skolnick MH, Goldgar DE, Simard J (1996) Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet 5:835–842. doi:10.1093/hmg/5.6.835 CrossRefPubMed Durocher F, Shattuck-Eidens D, McClure M, Labrie F, Skolnick MH, Goldgar DE, Simard J (1996) Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet 5:835–842. doi:10.​1093/​hmg/​5.​6.​835 CrossRefPubMed
25.
Zurück zum Zitat Dunning AM, Chiano M, Smith NR, Dearden J, Gore M, Oakes S, Wilson C, Stratton M, Peto J, Easton D, Clayton D, Ponder BA (1997) Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 6:285–289. doi:10.1093/hmg/6.2.285 CrossRefPubMed Dunning AM, Chiano M, Smith NR, Dearden J, Gore M, Oakes S, Wilson C, Stratton M, Peto J, Easton D, Clayton D, Ponder BA (1997) Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 6:285–289. doi:10.​1093/​hmg/​6.​2.​285 CrossRefPubMed
Metadaten
Titel
A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women
verfasst von
Zhanwei Wang
Yan Xu
Jinhai Tang
Hongxia Ma
Jianwei Qin
Chen Lu
Xuechen Wang
Zhibin Hu
Xinru Wang
Hongbing Shen
Publikationsdatum
01.11.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0327-z

Weitere Artikel der Ausgabe 1/2009

Breast Cancer Research and Treatment 1/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.